Ohio State offers new hope for patients with depression
You may qualify for a new treatment for depression being offered at OSU Harding Behavioral Health.
We are now conducting Transcranial Magnetic Stimulation (TMS) Therapy at OSU Harding Hospital. TMS is a FDA-approved non-drug treatment for depression that uses magnetic pulses to stimulate areas of the brain thought to control mood.
Approved by the FDA in 2008, TMS:
- Is suggested for patients who have not benefitted from antidepressant medication
- Is free of side effects typically associated with these medications
- Is given while you are awake and alert during treatment
- Allows you to resume normal activities upon leaving therapy
You need to meet basic criteria for TMS Therapy. You will receive an evaluation if you:
- Are 22-70 years of age
- Have Major Depressive Disorder diagnosis
- Have not benefitted from at least one antidepressant medication at or above the minimal effective dose and duration in the current depressive episode
For more information about TMS therapy or to schedule an evaluation, contact TMS Coordinator Mollie Gardner, RN, at Mollie.Gardner@osumc.edu or 614-293-8552.
Call to schedule an evaluation if you:
- are 22-70 years of age.
- have Major Depressive Disorder diagnosis.
- have not benefitted from at least one antidepressant medication at or above the minimal effective dose and duration in the current depressive episode.
Learn more about TMS Therapy at http://NeuroStar.com.
Efficacy for NeuroStar TMS Therapy was established in a controlled clinical trial comparing active treatment with the NeuroStar TMS Therapy system to an inactive device. Patients treated with active NeuroStar TMS Therapy received an average reduction in their depression symptom score of 22.1% compared to a 9% average reduction in patients receiving inactive treatment.
NeuroStar TMS Therapy is contraindicated in patients with implanted metallic devices or non-removable metallic objects in or around the head.